Board meeting on November 04, 2026 to approve September quarter results
Marksans Pharma has informed the exchanges that its Board of Directors will meet on Wednesday, November 04, 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Wednesday, November 04, 2026
- Period Covered
- quarter and half year ended September 30, 2026
- Trading Window Closure
- closed from October 01, 2026 till up to November 06, 2026 (both days inclusive)
The company has notified the exchanges of a scheduled Board meeting, which is a routine calendar item for a listed company.
What the meeting is for
- The Board will meet on Wednesday, November 04, 2026.
- The main agenda is to consider and approve the Unaudited Financial Results of the company for the quarter and half year ended September 30, 2026.
- Both Standalone and Consolidated results are to be considered and approved.
Trading window closure
- Under the insider trading rules and the company's internal code, the trading window for dealing in the company's shares is closed for Designated Persons (including Directors) and their immediate relatives.
- The closure started on October 01, 2026 and runs till Forty-Eight hours after the financial results are announced, i.e. up to November 06, 2026 (both days inclusive).
- In simple terms, people who are likely to have early access to the results are barred from buying or selling the shares during this period, so that everyone in the market gets the numbers at the same time.
Why it matters to a retail investor
- This notice tells you exactly when the company's April-September performance will become public.
- The results cover both the second quarter and the first half of the financial year, so they give a broader picture than a single quarter alone.
- Until the results are declared, the announcement itself contains no revenue, profit or margin numbers, so there is nothing here to judge performance on.
What to watch
- The actual Unaudited Financial Results, standalone and consolidated, expected around the meeting date.
- Any other matter that the Board takes up at the meeting, if disclosed separately.
In short, this is a scheduling notice: it fixes the date on which the company's September quarter and half-year numbers will be considered and approved, and it records the insider trading window closure around that date.
More numbers
- Trading window closed till, after results announcementForty-Eight hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.